News

TORONTO, January 16, 2003 (LifeSiteNews.com) – Diane-35, a drug permitted in Canada to treat severe acne is also being widely prescribed as a birth control pill. The abortifacient drug, was one of the first prescription drugs allowed to be actively marketed in Canada.  Slick ads with sexual innuendo were shown on television and movie theatres, but the ads left the medication’s exact purpose up to the imagination.  Following the ads, the makers of the drug saw Canadian sales shoot up 45 percent in one year alone, and more than 800,000 prescriptions for it were written last year.

CBC’s Disclosure program investigated the matter finding that the drug, which was mandated by Health Canada not to be prescribed as primarily birth control, was nevertheless being prescribed as such by doctors and gynecologists.  Berlex Canada, the drug’s Canadian distributors, are currently under investigation by Health Canada.  Diane-35’s use is restricted in Europe where it was first allowed as a double action birth control pill and acne medication. An inquest in England confirmed that the drug helped cause a blood clot that killed a young woman named Melanie Pyke.  Currently it is permitted in Europe as in Canada only to treat severe acne.  CBC reports that a coroner has confirmed that the death of young Ottawa woman Catherina Agelidis could be linked to Diane-35.  See the CBC Disclosure coverage:  https://cbc.ca/disclosure/archives/030114_diane/main.html

Comments

Commenting Guidelines

LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.